Back to Search
ASHLEY MARCUS, M.D.
M.D.
Physical Medicine & Rehabilitation Physician
NPI: 1710248430IndividualAccepts Medicare
Specialties, Licenses & Credentials
Physical Medicine & Rehabilitation PhysicianPrimary
Physical Medicine & Rehabilitation
Code: 208100000X
277148(NY)
Education
OTHER
Class of 2012
Research & Publications (20)
Role of CD39 (NTPDase-1) in thromboregulation, cerebroprotection, and cardioprotection.
PMID 15852226·Semin Thromb Hemost·2005
6-review
Heterologous cell-cell interactions: thromboregulation, cerebroprotection and cardioprotection by CD39 (NTPDase-1).
PMID 14675084·J Thromb Haemost·2003
6-review
Thromboregulation by endothelial cells: significance for occlusive vascular diseases.
PMID 11156849·Arterioscler Thromb Vasc Biol·2001
8-other
Inhibition of platelet recruitment by endothelial cell CD39/ecto-ADPase: significance for occlusive vascular diseases.
PMID 11770867·Ital Heart J·2001
7-preclinical
Self-regulation of inflammatory cell trafficking in mice by the leukocyte surface apyrase CD39.
PMID 19381014·J Clin Invest·2009
7-preclinical
P2X(1) receptor inhibition and soluble CD39 administration as novel approaches to widen the cardiovascular therapeutic window.
PMID 19467446·Trends Cardiovasc Med·2009
6-review
II. Kinetic pathways of switching optical conformations in DsRed by 2D Fourier imaging correlation spectroscopy.
PMID 19368361·J Phys Chem B·2009
7-preclinical
Optimization of a series of quinazolinone-derived antagonists of CXCR3.
PMID 19632842·Bioorg Med Chem Lett·2009
7-preclinical
Excited state intramolecular proton transfer and photophysics of a new fluorenyl two-photon fluorescent probe.
PMID 19449363·Chemphyschem·2009
7-preclinical
I. Conformational dynamics of biological macromolecules by polarization-modulated Fourier imaging correlation spectroscopy.
PMID 19368366·J Phys Chem B·2009
7-preclinical
Modulation of choroidal neovascularization by subretinal injection of retinal pigment epithelium and polystyrene microbeads.
PMID 19158960·Mol Vis·2009
7-preclinical
An inhibitory metabolite leads to dose- and time-dependent pharmacokinetics of (R)-N-{1-[3-(4-ethoxy-phenyl)-4-oxo-3,4-dihydro-pyrido[2,3-d]pyrimidin-2-yl]-ethyl}-N-pyridin-3-yl-methyl-2-(4-trifluoromethoxy-phenyl)-acetamide (AMG 487) in human subjects after multiple dosing.
PMID 19088267·Drug Metab Dispos·2009
2-rct
The LIVESTRONG Survivorship Center of Excellence Network.
PMID 19169829·J Cancer Surviv·2009
4-observational
Fetal stem cells from extra-embryonic tissues: do not discard.
PMID 18194447·J Cell Mol Med·2008
6-review
Kinetic experiments for evaluating the Nernst-Monod model for anode-respiring bacteria (ARB) in a biofilm anode.
PMID 18800535·Environ Sci Technol·2008
8-other
Tailored behavioral support for smoking reduction: development and pilot results of an innovative intervention.
PMID 17884837·Health Educ Res·2008
2-rct
Optimization of the heterocyclic core of the quinazolinone-derived CXCR3 antagonists.
PMID 18061451·Bioorg Med Chem Lett·2008
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 2781 SHELL RD STE 101
BROOKLYN, NY 11223 - Phone
- (718) 648-1234
Quick Facts
- NPI
- 1710248430
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 14
- Publications
- 20
Are you this provider?
Claim Your Profile